Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblasts

Schulz, F; Nachtkamp, K; Kasprzak, A; Gattermann, N; Haas, R; Germing, U

Germing, U (corresponding author), Univ Hosp Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany.

EXPERT REVIEW OF HEMATOLOGY, 2021; 14 (6): 509

Abstract

Introduction Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic stem cell diseases characterized by cell dysplasia, ineffectiv......

Full Text Link